About Biomesight
Biomesight is a Healthcare company based in London (United Kingdom) founded in 2019. It offers gut microbiome analysis, testing kits, and personalized supplement recommendations. It operates on a D2C and B2B model. Biomesight offers products and services including Microbiome Testing Kit and Analytics Platform. Its focus areas include Health and Wellness, Biotech, Microbiome Analysis and Gut Health Testing. Its legal entity is PEERQUITY LTD. Its competitors include Juno Bio, Atlas Biomed, OMED Health and Nylos.
Company details
Biomesight is a wellness analytics platform that analyzes gut microbiomes using 16S rRNA sequencing technology. Users order testing kits, submit samples, and receive detailed reports with gut health scores, bacterial abundance, and personalized recommendations for food, supplements, and lifestyle adjustments. Based in London, United Kingdom, it serves individuals, practitioners, researchers, and corporations through direct sales and partnerships, focusing on improving digestive health and related conditions like SIBO and autoimmune issues.
Products & Services of Biomesight
Biomesight offers a comprehensive portfolio of products and services, including Microbiome Testing Kit and Analytics Platform.
Kit for gut microbiome analysis and health score generation.
Platform for viewing microbiome results and personalized recommendations.
Apps and channels of Biomesight
its YouTube channel Biomesight has 543 subscribers and 23 videos.
Videos from Biomesight
The most watched videos on Biomesight's YouTube channel, Biomesight (543 subscribers). Click a video to play it here.
More on Biomesight.
Competitors of Biomesight
Biomesight has 4 listed competitors in our database. They include Juno Bio, Atlas Biomed, OMED Health and Nylos, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| juno.bio | 2018 | London, United Kingdom | – | 5 | Microbiome-focused research services are provided by Juno Bio. | |
| atlasbiomed.com | 2013 | London, United Kingdom | – | 1 | Genetic tests are offered via DNA and gut microbiome analysis. | |
| omedhealth.com | 2022 | Cambridge, United Kingdom | – | 199 | Offers at-home breath testing and treatment for digestive health conditions. | |
| nylos.me | 2019 | London, United Kingdom | – | – | Offers online gut microbiome testing for personalized diet planning. |
Detailed competitors of Biomesight
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Microbiome Therapeutics
10 companies that operate in the same segment as Biomesight (Microbiome Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | Bags Sword, Denmark | – | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Gut microbiome insights, analytics, tests, and therapeutics are provided. | 2019 | Singapore, Singapore | USD 10.5 M | USD 1.37 M | – | |
Microbiome-based therapeutics for skin conditions like eczema are developed. | 2014 | Farmington, United States | USD 37.4 M | – | 12 | |
Engineered microbes are developed as programmable therapeutics for metabolic disorders. | 2013 | Cambridge, Massachusetts, United States | USD 34.4 M | USD 8 K | 1 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Microbiome-based therapeutics for gut diseases are developed. | 2017 | Edinburgh, Scotland, United Kingdom | USD 72.96 M | – | 65 | |
The gut-brain axis is explored for therapeutic and nutritional innovations. | 2014 | New York, New York, United States | USD 479 M | – | 84 | |
Microbiome therapeutics are developed to address diverse diseases. | 2010 | Cambridge, Massachusetts, United States | USD 257.13 M | USD 789 K | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biomesight
Biomesight was founded in 2019.
Biomesight is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Biomesight is a wellness analytics platform that analyzes gut microbiomes using 16S rRNA sequencing technology. Users order testing kits, submit samples, and receive detailed reports with gut health scores, bacterial abundance, and personalized recommendations for food, supplements, and lifestyle adjustments. Based in London, United Kingdom, it serves individuals, practitioners, researchers, and corporations through direct sales and partnerships, focusing on improving digestive health and related conditions like SIBO and autoimmune issues.
Biomesight's top competitors include Juno Bio, Atlas Biomed and OMED Health.
Biomesight offers Microbiome Testing Kit and Analytics Platform.
Biomesight operates through Peerquity Ltd.